IRMD
IRadimed Corporation
NASDAQ · USHealthcareMedical - Devices
$97.03+0.00%
Price as of Jul 20, 2026
IRMD financials
IRadimed Corporation financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $83.8M | $73.2M | $65.6M | $53.3M |
| Cost of revenue | $19.5M | $16.9M | $15.4M | $12.0M |
| Gross profit | $64.3M | $56.3M | $50.2M | $41.3M |
| Operating expenses | $38.2M | $34.4M | $30.1M | $25.7M |
| Operating income | $26.1M | $22.0M | $20.0M | $15.6M |
| Net income | $22.5M | $19.2M | $17.2M | $12.8M |
| EBITDA | $30.7M | $25.1M | $22.5M | $16.9M |
| Basic EPS | $1.77 | $1.52 | $1.36 | $1.02 |
| Diluted EPS | $1.75 | $1.50 | $1.35 | $1.02 |
| Balance sheet | ||||
| Cash & equivalents | $51.2M | $52.2M | $49.8M | $58.0M |
| Total assets | $108.8M | $98.3M | $92.2M | $85.5M |
| Total liabilities | $14.2M | $11.5M | $20.7M | $11.8M |
| Stockholders’ equity | $94.6M | $86.8M | $71.4M | $73.7M |
| Total debt | $0.00 | $154.7K | $2.0M | $2.2M |
| Net debt | -$51.2M | -$52.1M | -$47.7M | -$55.8M |
| Cash flow | ||||
| Operating cash flow | $24.9M | $25.6M | $13.5M | $10.0M |
| Capital expenditure | -$7.8M | -$8.0M | -$8.0M | -$1.9M |
| Free cash flow | $17.2M | $17.6M | $5.5M | $8.2M |
| Dividends paid | -$15.0M | -$13.7M | -$13.2M | -$12.6M |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |